Annovis Bio ANVS SEC Filings

NYSE ANVS
$1.23 -0.07 (-5.38%)
As of: Sep 9, 2026 · 3:59 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Annovis Bio, Inc. (ANVS) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index